These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 18784598

  • 1. Clinical comparisons of botulinum neurotoxin formulations.
    Brashear A.
    Neurologist; 2008 Sep; 14(5):289-98. PubMed ID: 18784598
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Use of botulinum neurotoxin for spasticity].
    Mukai Y, Kaji R.
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum neurotoxins in the treatment of refractory pain.
    Jabbari B.
    Nat Clin Pract Neurol; 2008 Dec; 4(12):676-85. PubMed ID: 19043424
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin treatment of secretory disorders.
    Naumann M, Jost W.
    Mov Disord; 2004 Mar; 19 Suppl 8():S137-41. PubMed ID: 15027066
    [Abstract] [Full Text] [Related]

  • 11. [Clinical use of botulinum toxin].
    Jost WH.
    Nervenarzt; 2008 Jun; 79 Suppl 1():9-14. PubMed ID: 18927958
    [Abstract] [Full Text] [Related]

  • 12. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.
    Chen JJ, Dashtipour K.
    Pharmacotherapy; 2013 Mar; 33(3):304-18. PubMed ID: 23400888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emerging therapeutic applications of botulinum toxin.
    Thant ZS, Tan EK.
    Med Sci Monit; 2003 Feb; 9(2):RA40-8. PubMed ID: 12601305
    [Abstract] [Full Text] [Related]

  • 18. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
    Wortzman MS, Pickett A.
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
    Naumann M, Dressler D, Hallett M, Jankovic J, Schiavo G, Segal KR, Truong D.
    Toxicon; 2013 Jun 01; 67():141-52. PubMed ID: 23178324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.